Last week Dr. Andrew C. Von Eschenbach, Director of the National Cancer Institute (NCI), and other senior leaders of NCI were in Dallas, Texas to host a retreat of the directors of all NCI-designated Cancer Centers. The third retreat of its type, its goal was to “encourage frank discussions and gain honest input from the directors on some of the most pressing issues facing NCI” (NCI Cancer Bulletin, November 15, 2005 edition).
The article, authored by Dr. von Eschenbach, went on to say:
“The directors recognize the essential role the Cancer Centers must play if we are to eliminate the suffering and death due to cancer. However, there were concerns among many that the timeline is too ambitious. At the same time, they recognized the substantial opportunities for real progress in the years ahead and were supportive of working with NCI leadership to establish intermediate milestones for reaching the 2015 goal.”
The Center Directors received updates on current NCI operations and priorities as well as an in-depth analysis of NCI’s fiscal year 2006 projeccted budget. Dr. Anthony Hayward of the National Center for Research Resources answered questions about the National Institutes of Health’s (NIH) new Clinical & Translational Science Awards program.
Dr. von Eschenbach ended the article by stating:
“The Center Directors’ collective experience and unabated commitment to their institutions, as well as to quality research and patient care, makes this retreat an invaluable planning tool. I know I speak for the entire senior leadership team when I say we are fortunate to have access to such a talented groups of individuals. It’s their dedication, and the commitment to excellence they have imbued in the staff at their respective centers, that makes 2015 an attainable goal.
Click here to read the entire article as published in the November 15, 2005 edition of the NCI Cancer Bulletin.